Pathologic reassessment of prostate cancer surgical specimens before molecular retrospective studies

Clinical Cancer Research

Volumn 17, Issue 4, 2011, Pages 836-840

  Fromont, Gaelle ^a   Validire, Pierre ^b   Prapotnich, Dominique ^b   Rozet, François ^b   Vallancien, Guy ^b   Cussenot, Olivier ^c   Cathelineau, Xavier ^b  

^a UNIVERSITÉ DE POITIERS   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SCORING SYSTEM; TISSUE SECTION;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 79951822466     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1046     Document Type: Article

References (18)

1. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-74. (Pubitemid 28445094)
2. Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2002;20:3206-12. (Pubitemid 34831516)
3. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167:528-34. (Pubitemid 34074521)
4. Guillonneau B, Abou El Fettouh H, et al. Laparoscopic radical prostatectomy for renal tumor : oncological evaluation after 1000 cases at montsouris institute. J Urol 2003;169:1261-6. (Pubitemid 36323763)
5. Mian BM, Troncoso P, Okihara K, et al. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 2003;167:1675-80.
6. Van Poppel H, Joniau S. An analysis of radical prostatectomy in advanced stage and high grade prostate cancer. Eur Urol 2008;53: 253-9. (Pubitemid 350296585)
7. Gofrit ON, Zorn KC, Steinberg GD, Zagaja GP, Shalhav AL. The Will Rogers phenomenon in urological oncology. J Urol 2008;179:28-33. (Pubitemid 350216727)
8. Ravery V, De la Taille A, Toublanc M, et al. Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence. J Urol 1996;155:1981-2. (Pubitemid 26144098)
9. Miyamoto H, Hernandez DJ, Epstein JI. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy. Human Pathol 2009; 40:1693-8.
10. Stark JR, Perner S, Stampfer MJ, et al. Gleason score and lethal prostate cancer: does 3+4 = 4+3?JCO 2009;27:3459-64.
11. Epstein JI, Allsbrook WC, Amin MB, Egevad LL, ISUP grading Committee. The 2005 international society of urological pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005;29,1228-42.
12. Albertsen PC, Hanley JA, Barrows GH, et al. Prostate cancer and the Will Rogers Phenomenon. J Natl Cancer Inst 2005;97:1248-53. (Pubitemid 41535365)
13. Kuroiwa K, Uchino H, Yokomizo A, Naito S. Impact of reporting rules of biopsy Gleason score for prostate cancer. J Clin Pathol 2009;62: 260-3.
14. Chism DB, Hanlon AL, Troncoso P, Al-Saleem T, Horwitz EM, Pollack A. The Gleason score shift: score four and seven years ago. Int J Radiation Oncology Biol Phys 2003;56:1241-7. (Pubitemid 36842874)
15. Evans AJ, Henry PC, Van Der Kwast TH, et al. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens. Am J Surg Pathol 2008;32:1503-12.
16. Swindle P, Eastham JA, Ohori M, et al. Do margin matter? The prognostic significance of positive surgical margins in radical prostatectomy specimen. J Urol 2005;174:903-7. (Pubitemid 41140626)
17. Chuang AY, Nielsen ME, Hernandez DJ, Walsch PC, Epstein JI. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. J Urol 2007;178:1306-10. (Pubitemid 47368418)
18. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 2005;23:9067-72.